Literature DB >> 24759840

Brugada syndrome in spinal and bulbar muscular atrophy.

Amane Araki1, Masahisa Katsuno2, Keisuke Suzuki1, Haruhiko Banno1, Noriaki Suga1, Atsushi Hashizume1, Tomoo Mano1, Yasuhiro Hijikata1, Hideaki Nakatsuji1, Hirohisa Watanabe1, Masahiko Yamamoto1, Takeru Makiyama1, Seiko Ohno1, Megumi Fukuyama1, Shin-Ichiro Morimoto1, Minoru Horie1, Gen Sobue2.   

Abstract

OBJECTIVE: The aim of this study was to clarify myocardial involvement and its clinical implications in subjects with spinal and bulbar muscular atrophy (SBMA), a neuromuscular disease affecting both neuronal and nonneuronal tissues.
METHODS: Two independent cardiologists evaluated ECGs from a total of 144 consecutive subjects with SBMA. We performed immunohistochemical, immunoblot, and quantitative real-time PCR analyses of autopsied myocardium.
RESULTS: Abnormal ECGs were detected in 70 (48.6%) of 144 subjects. The most frequent findings were ST-segment abnormalities in V1-3 (19.4%), followed by ST-segment abnormalities in V5-6 (18.1%). We detected Brugada-type ECGs in 17 of 28 subjects with ST-segment abnormalities in V1-3. Of those, one subject presented with syncope that required an implantable cardioverter defibrillator and led to eventual sudden death, and another subject also died suddenly. No subjects with Brugada-type ECGs had mutations in SCN5A, CACNA1C, or CACNB2 genes. In autopsied cases, we detected nuclear accumulation of the mutant androgen receptor protein and decreased expression levels of SCN5A in the myocardium.
CONCLUSIONS: Subjects with SBMA often show Brugada-type ECG. The accumulation of the pathogenic androgen receptor may have a role in the myocardial involvement in SBMA.
© 2014 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24759840     DOI: 10.1212/WNL.0000000000000434

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

Review 1.  Spinal and Bulbar Muscular Atrophy.

Authors:  Christopher Grunseich; Kenneth H Fischbeck
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

Review 2.  Emergencies in motoneuron disease.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Intern Emerg Med       Date:  2017-03-09       Impact factor: 3.397

Review 3.  Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease.

Authors:  Marianthi Breza; Georgios Koutsis
Journal:  J Neurol       Date:  2018-07-13       Impact factor: 4.849

Review 4.  Heart Disease in Disorders of Muscle, Neuromuscular Transmission, and the Nerves.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Korean Circ J       Date:  2016-03-21       Impact factor: 3.243

5.  Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes.

Authors:  Carmelo Milioto; Adriana Malena; Eleonora Maino; Maria J Polanco; Caterina Marchioretti; Doriana Borgia; Marcelo Gomes Pereira; Bert Blaauw; Andrew P Lieberman; Roberta Venturini; Mario Plebani; Fabio Sambataro; Lodovica Vergani; Elena Pegoraro; Gianni Sorarù; Maria Pennuto
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

6.  Only some patients with bulbar and spinal muscular atrophy may develop cardiac disease.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Mol Genet Metab Rep       Date:  2017-12-21

7.  Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy.

Authors:  Robert D Guber; Varun Takyar; Angela Kokkinis; Derrick A Fox; Hawwa Alao; Ilona Kats; Dara Bakar; Alan T Remaley; Stephen M Hewitt; David E Kleiner; Chia-Ying Liu; Colleen Hadigan; Kenneth H Fischbeck; Yaron Rotman; Christopher Grunseich
Journal:  Neurology       Date:  2017-11-15       Impact factor: 9.910

Review 8.  Neuro-Cardio Mechanisms in Huntington's Disease and Other Neurodegenerative Disorders.

Authors:  Bethan J Critchley; Mark Isalan; Michal Mielcarek
Journal:  Front Physiol       Date:  2018-05-23       Impact factor: 4.566

9.  Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients.

Authors:  Giorgia Querin; Cinzia Bertolin; Elisa Da Re; Marco Volpe; Gabriella Zara; Elena Pegoraro; Nicola Caretta; Carlo Foresta; Maria Silvano; Domenico Corrado; Massimo Iafrate; Lorenzo Angelini; Leonardo Sartori; Maria Pennuto; Alessandra Gaiani; Luca Bello; Claudio Semplicini; Davide Pareyson; Vincenzo Silani; Mario Ermani; Alberto Ferlin; Gianni Sorarù
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-10-26       Impact factor: 10.154

10.  Impaired muscle uptake of creatine in spinal and bulbar muscular atrophy.

Authors:  Yasuhiro Hijikata; Masahisa Katsuno; Keisuke Suzuki; Atsushi Hashizume; Amane Araki; Shinichiro Yamada; Tomonori Inagaki; Madoka Iida; Seiya Noda; Hirotaka Nakanishi; Haruhiko Banno; Tomoo Mano; Akihiro Hirakawa; Hiroaki Adachi; Hirohisa Watanabe; Masahiko Yamamoto; Gen Sobue
Journal:  Ann Clin Transl Neurol       Date:  2016-06-23       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.